Łukasz Berlicki

From Bioorganic
Revision as of 09:17, 9 July 2021 by Berlicki (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Berlicki2.jpg


Married: Anna, three sons Jan, Stanisław and Franciszek (2006, 2012, 2017).

Hobby: travel photography, LEGO bricks.

e-mail: lukasz.berlicki@pwr.wroc.pl

ORCID: 0000-0003-0318-4944

Scopus ID 6507332551

WoS Researcher ID AAB-2140-2019

Google Scholar

Education

  • 2020 — professor of Chemistry, Faculty of Chemistry, Wrocław University of Science and Technology.
  • 2012 — habilitation in Chemistry, Faculty of Chemistry, Wrocław University of Technology, Habilitation thesis: “Design and analysis of structure-activity relationships of inhibitors of urease and glutamine synthetase”.
  • 2004 — PhD in Chemistry (with honors), Faculty of Chemistry, Wrocław University of Technology, Doctoral thesis „Design and synthesis of glutamine synthetase inhibitors”, supervisor: Prof. Paweł Kafarski.
  • 2000 — MSc in Chemistry, Faculty of Chemistry, University of Wrocław, Master thesis „Synthesis of chiral carbodiimides”, supervisor: Prof. Ignacy Siemion.
  • 2000 — MSc Eng. in Computer Science, Faculty of Electronics, Wrocław University of Technology, Master thesis „Codes with public keys”, supervisor: Prof. Jerzy Kisilewicz.

Employment

  • 2020 - to date, Professor, Department of Bioorganic Chemistry, Wrocław University of Technology.
  • 2014 - 2020, Associate Professor, Department of Bioorganic Chemistry, Wrocław University of Technology.
  • 2006 – 2014, Assistant Professor, Department of Bioorganic Chemistry, Wrocław University of Technology.
  • 2004 – 2006, Researcher, Department of Bioorganic Chemistry, Wrocław University of Technology.

Fellowships and scientific visits

  • Germany, University of Regensburg, Prof. Oliver Reiser Group, 7th Framework Programme/People, Marie Curie Intra-European Fellowships, acronym: CANPY (No 236579), 2009-2010 (12 months);
  • Germany, Ruhr University Bochum, Faculty of Chemistry, 2010 (1 week);
  • Spain, Autonomous University of Barcelona, Department of Chemistry, 2010 (1 week);
  • Greece, University of Athens, Department of Chemistry, 2006 (1 week);
  • Greece, University of Athens, Department of Chemistry, 2004 (1 week);
  • Italy, University of Bari, Department of Chemistry, Prof. M. Aresta Group, Socrates/Erasmus stage, 1999 (3 months).

Research interests

  • Computer-aided design of novel enzyme inhibitors.
  • Analysis of ligand-receptor (particularly enzyme) interactions with the use of molecular modeling and nuclear magnetic resonance techniques.
  • Stereo-controlled synthesis of biologically active compounds, particularly, analogues of amino acids and peptides.
  • Design and structural analysis (NMR, CD) of peptides that show well defined three-dimensional structure.

International research co-operations

Publications

  1. Stanojlovic, V.; Müller, A.; Moazzam, A.; Hinterholzer, A.; Ożga, K.; Berlicki, Ł.; Schubert, M.; Cabrele, C., A conformationally stable acyclic β-hairpin scaffold tolerating the incorporation of poorly β-sheet-prone amino acids ChemBioChem 2022, 23, e202100604. View at Publisher
  2. Vassiliou, S.; Pagoni, A.; Węglarz-Tomczak, E.; Talma, M.; Tabor, W.; Grabowiecka, A.; Berlicki, Ł.; Mucha, A., Phosphinic acid-based enzyme inhibitors Phos. Sulph. Rel. El. 2022, 197, 451. View at Publisher
  3. Szefczyk, M.; Ożga, K.; Drewniak-Świtalska, M.; Rudzińska-Szostak, E.; Hołubowicz, R.; Ożyhar, A.; Berlicki, Ł., Controlling the conformational stability of coiled-coil peptides with a single stereogenic center of a peripheral β-amino acid residue RSC Adv. 2022, 12, 4640. View at Publisher
  4. Loharch, S.; Berlicki, Ł., Rational Development of Bacterial Ureases Inhibitors Chem. Rec. 2022, 22, e202200026. View at Publisher
  5. Ożga, K.; Berlicki, Ł., Design and Engineering of Miniproteins ACS Bio Med Chem Au 2022, 2, 316. View at Publisher
  6. Ciesiołkiewicz, A.; Lizandra Perez, J.; Berlicki, Ł., Miniproteins in medicinal chemistry Bioorg. Med. Chem. Lett. 2022, 71, 128806. View at Publisher
  7. Berlicki, Ł., Tailoring peptides and peptidomimetics for targeting protein-protein interactions in Peptide and Peptidomimetic Therapeutics (N. Qvit, S. J. S. Rubin Eds.) 2022, 57. View at Publisher
  8. Pagoni, A.; Grabowiecka, A.; Tabor, W.; Mucha, A.; Vassiliou, S.; Berlicki, Ł., Covalent Inhibition of Bacterial Urease by Bifunctional Catechol-Based Phosphonates and Phosphinates J. Med. Chem. 2021, 64, 404. View at Publisher
  9. Szefczyk, M.; Szulc, N.; Gąsior-Głogowska, M.; Modrak-Wójcik, A.; Bzowska, A.; Majstrzyk, W.; Taube, M.; Kozak, M.; Gotszalk, T.; Rudzińska-Szostak, E.; Berlicki, Ł., Hierarchical approach for the rational construction of helix-containing nanofibrils using α,β-peptides. Nanoscale 2021, 13, 4000. View at Publisher
  10. Drewniak, M.; Barycza, B.; Rudzińska-Szostak, E.; Morawiak, P.; Berlicki, Ł., Constrained beta-amino acid-containing miniproteins Org. Biomol. Chem. 2021, 19, 4272. View at Publisher
  11. Ożga, K.; Drewniak-Świtalska, M.; Rudzińska-Szostak, E.; Berlicki, Ł., Towards Foldameric Miniproteins: A Helix‐Turn‐Helix Motif ChemPlusChem 2021, 86, 646. View at Publisher
  12. Bejger, M.; Fortuna, P.; Drewniak, M.; Plewka, J.; Rypniewski, W.; Berlicki, Ł., A computationally designed β-amino acid-containing miniprotein. Chem. Commun. 2021, 57, 6015. View at Publisher
  13. Grelich-Mucha, M.; Garcia, A. M.; Torbeev, V.; Ożga, K.; Berlicki, Ł.; Olesiak-Bańska, J., Autofluorescence of Amyloids Determined by Enantiomeric Composition of Peptides J. Phys. Chem. B 2021, 125, 5502. View at Publisher
  14. Tarczewska, A.; Wycisk, K.; Orłowski, M.;Waligórska, A.; Dobrucki, J.; Drewniak-Świtalska, M.; Berlicki, Ł.; Ożyhar, A., Nuclear immunophilin FKBP39 from Drosophila melanogaster drives spontaneous liquid-liquid phase separation. Int. J. Biol. Macromol. 2020, 163, 108. View at Publisher
  15. Fortuna, P.; Linhares, B. M.; Purohit, T.; Pollock, J.; Cierpicki, T.; Grembecka, J.; Berlicki, Ł., Covalent and noncovalent constraints yield a figure eight-like conformation of a peptide inhibiting the menin-MLL interaction Eur. J. Med. Chem. 2020, 207, 112748. View at Publisher
  16. Fortuna, P.; Twarda-Clapa, A.; Skalniak, L.; Ożga, K.; Holak, T. A.; Berlicki, Ł., Systematic ‘foldamerization’ of peptide inhibiting p53-MDM2/X interactions by the incorporation of trans- or cis-2-aminocyclopentanecarboxylic acid residues Eur. J. Med. Chem. 2020, 208, 112814. View at Publisher
  17. Burda‐Grabowska, M.; Macegoniuk, K.; Flick, R.; Nocek, B. P.; Joachimiak, A.; Yakunin, A. F.; Mucha, A.; Berlicki, Ł., Bisphosphonic acids and related compounds as inhibitors of nucleotide‐ and polyphosphate‐processing enzymes: A PPK1 and PPK2 case study. Chem. Biol. Drug Des. 2019, 93, 1197. View at Publisher
  18. Pagoni, A.; Daliani, T.; Macegoniuk, K.; Vassiliou, S.; Berlicki, Ł., Catechol-based inhibitors of bacterial urease Bioorg. Med. Chem. Lett. 2019, 29, 1085. View at Publisher
  19. Drewniak, M.; Węglarz-Tomczak, E.; Ożga, K.; Rudzińska-Szostak, E.; Macegoniuk, K.; Tomczak, J. M.; Bejger, M.; Rypniewski, W.; Berlicki, Ł., Helix-loop-helix peptide foldamers and their use in the construction of hydrolase mimetics. Bioorg. Chem. 2018, 81, 356. View at Publisher
  20. Ntatsopoulos, V.; Macegoniuk, K.; Mucha, A.; Vassiliou, S.; Berlicki, Ł., Structural exploration of cinnamate-based phosphonic acids as inhibitors of bacterial ureases. Eur. J. Med. Chem. 2018, 159, 307. View at Publisher
  21. Nocek, B. P.; Khusnutdinova, A. N.; Ruszkowski, M.; Flick, R.; Burda, M.; Batyrova, K.; Brown, G.; Mucha, A.; Joachimiak, A.; Berlicki, Ł.; Yakunin, A. F., Structural insights into substrate selectivity and activity of bacterial polyphosphate kinases ACS Catal. 2018, 8, 10746. View at Publisher
  22. Giberti, S.; Bertazzini, M.; Liboni, M.; Berlicki, Ł.; Kafarski, P.; Forlani, G., Phytotoxicity of aminobisphosphonates targeting both δ1-pyrroline-5-carboxylate reductase and glutamine synthetase Pest Manag. Sci. 2017, 72, 435. View at Publisher
  23. Szefczyk, M.; Węglarz-Tomczak, E.; Fortuna, P.; Krzysztoń, A.; Rudzińska-Szostak, E.; Berlicki, Ł., Controlling the Helix Handedness of ααβ-Peptide Foldamers through Sequence Shifting Angew. Chem. Int. Ed. 2017, 56, 2087. View at Publisher
  24. Macegoniuk, K.; Kowalczyk, R.; Rudzińska, A.; Psurski, M.; Wietrzyk, J.; Berlicki, Ł., Potent covalent inhibitors of bacterial urease identified by activity-reactivity profiling Bioorg. Med. Chem. Lett. 2017, 27, 1346. View at Publisher
  25. Ntatsopoulos, V.; Vassiliou, S.; Macegoniuk, K.; Berlicki, Ł.; Mucha, A., Novel organophosphorus scaffolds of urease inhibitors obtained by substitution of Morita-Baylis-Hillman adducts with phosphorus nucleophiles Eur. J. Med. Chem. 2017, 133, 107. View at Publisher
  26. Wavhale, R. D.; Martis, E. A. F.; Ambre, P. K.; Wan, B.; Franzblau, S. G.; Iyer, K. R.; Raikuvar, K.; Macegoniuk, K.; Berlicki, Ł.; Nandan, S. R.; Coutinho, E. C., Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity Bioorg. Med. Chem. 2017, 25, 4835. View at Publisher
  27. Macegoniuk, K.; Grela, E.; Biernat, M.; Psurski, M.; Gościniak, G.; Dziełak, A.; Mucha, A.; Wietrzyk, J.; Berlicki, Ł.; Grabowiecka, A., Aminophosphinates against Helicobacter pylori ureolysis—Biochemical and whole-cell inhibition characteristics PLoS One 2017, 1, 182437. View at Publisher
  28. Rudzińska-Szostak, E.; Berlicki, Ł., Sequence engineering to control the helix handedness of peptide foldamers Chem. Eur. J. 2017, 23, 14980. View at Publisher
  29. Magiera-Mularz, K.; Skalniak, L.; Zak, K. M.; Musielak, B.; Rudzinska-Szostak, E.; Berlicki, Ł.; Kocik, J.; Grudnik, P.; Sala, D. Zarganes-Tzitzikas, T.; Shaabani, S.; Dömling, A.; Dubin, G.; Holak, T. A., Bioactive Macrocyclic Inhibitors of the PD-1/PD-L1 Immune Checkpoint Angew. Chem. Int. Ed. 2017, 56, 13732. View at Publisher
  30. Kosikowska, P.; Bochno, M.; Macegoniuk, K.; Forlani, G.; Kafarski, P.; Berlicki, Ł., Bisphosphonic acids as effective inhibitors of Mycobacterium tuberculosis glutamine synthetase J. Enz. Inh. Med. Chem. 2016, 31, 931. View at Publisher
  31. Wójcik, P.; Berlicki, Ł., Peptide-based inhibitors of protein–protein interactions. Bioorg. Med. Chem. Lett. 2016, 26, 707. View at Publisher
  32. Węglarz-Tomczak, E.; Berlicki, Ł.; Pawełczak, M.; Nocek, B.; Joachimiak, A. Mucha, A., A structural insight into the P1-S1 binding mode of diaminoethylphosphonic and phosphinic acids, selective inhibitors of alanine aminopeptidases. Eur. J. Med. Chem. 2016, 117, 187. View at Publisher
  33. Macegoniuk, K.; Grela, E.; Palus, J.; Rudzińska-Szostak, E.; Grabowiecka, A.; Biernat, M.; Berlicki, Ł., 1,2-Benzisoselenazol-3(2H)-one Derivatives As a New Class of Bacterial Urease Inhibitors. J. Med. Chem. 2016, 59, 8125. View at Publisher
  34. Macegoniuk, K.; Dziełak, A.; Mucha, A.; Berlicki, Ł., Bis(aminomethyl)phosphinic acid, a highly promising scaffold for the development of bacterial urease inhibitors. ACS Med. Chem. Lett. 2015, 6, 146. View at Publisher
  35. Rudzińska-Szostak, E.; Górecki, Ł. Berlicki, Ł.; Ślepokura, K.; Mucha, A., Zwitterionic Phosphorylated Quinines as Chiral Solvating Agents for NMR Spectroscopy Chirality 2015, 27, 752. View at Publisher
  36. Bochno, M.; Berlicki, Ł., A three-component synthesis of aminomethylenebis-H-phosphinates. Tetrahedron Lett. 2014, 55, 219. View at Publisher
  37. Cabrele, C.; Martinek, T. A.; Reiser, O.; Berlicki, Ł., Peptides Containing β-Amino Acid Patterns: Challenges and Successes in Medicinal Chemistry J. Med. Chem. 2014, 57, 9718. View at Publisher
  38. Vassiliou, S.; Węglarz-Tomczak, E.; Berlicki, Ł.; Pawełczak, M.; Nocek, B.; Mulligan, R.; Joachimiak, A.; Mucha, A., Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases. J. Med. Chem. 2014, 57, 8140. View at Publisher
  39. Węglarz-Tomczak, E.; Poręba, M.; Byzia, A.; Berlicki, Ł.; Nocek, B.; Mulligan, R.; Joachimiak, A.; Drąg, M.; Mucha, A., An integrated approach to the ligand binding specificity of Neisseria meningitidis M1 alanine aminopeptidase by fluorogenic substrate profiling, inhibitory studies and molecular modeling. Biochimie 2013, 95, 419. View at Publisher
  40. Benini, S.; Kosikowska, P.; Cianci, M.; Mazzei, L.; Vara, A. G.; Berlicki, Ł.; Ciurli, S., The crystal structure of Sporosarcina pasteurii urease in a complex with citrate provides new hints for inhibitor design. J. Biol. Inorg. Chem. 2013, 18, 391. View at Publisher
  41. Drąg, M.; Wieczerzak, E.; Pawełczak, M.; Berlicki, Ł.; Grzonka, Z.; Kafarski, P., Toward very potent, non-covalent organophosphonate inhibitors of cathepsin C and related enzymes by 2-amino-1-hydroxy-alkanephosphonates dipeptides. Biochemie 2013, 95, 1640. View at Publisher
  42. Forlani, G.; Berlicki, Ł.; Duò, M.; Dziędzioła, G.; Giberti, S.; Bertazzini, M.; Kafarski, P., Synthesis and Evaluation of Effective Inhibitors of Plant δ1-Pyrroline-5-carboxylate Reductase. J. Agric. Food Chem. 2013, 61, 6792. View at Publisher
  43. Berlicki, Ł.; Kaske, M.; Gutierrez-Abad, R.; Bernhardt, G.; Illa, O.; Ortuño, R. M.; Cabrele, C.; Buschauer, A.; Reiser, O., Replacement of Thr32 and Gln34 in the C-terminal neuropeptide Y fragment 25-36 by cis-cyclobutane- and cis-cyclopentane β-amino acids shifts selectivity toward the Y4 receptor. J. Med. Chem. 2013, 56, 8422. View at Publisher
  44. Berlicki, Ł.; Bochno, M.; Grabowiecka, A.; Białas, A.; Kosikowska, P.; Kafarski, P., N-Substituted aminomethanephosphonic and aminomethane-P-methylphosphinic acids as inhibitors of ureases. Amino Acids 2012, 42, 1937. View at Publisher
  45. Forlani, G.; Petrolino, D.; Fusetti M.; Romanini, L.; Nocek, B.; Joachimiak, A.; Berlicki, L.; Kafarski, P., Delta1-Pyrroline-5-carboxylate reductase as a new target for therapeutics: inhibition of the enzyme from Streptococcus pyogenes and effects in vivo. Amino Acids 2012, 42, 2283. View at Publisher
  46. Vassiliou, S.; Grabowiecka, A.; Kosikowska, P.; Berlicki, Ł., Three component Kabachnik-Fields condensation leading to substituted aminomethane-P-hydroxymethylphosphonic acids as a tool for screening of bacterial urease inhibitors ARKIVOC 2012, 2012, 33.
  47. Górecki, Ł.; Berlicki, Ł.; Mucha, A.; Kafarski, P.; Ślepokura, K.; Rudzińska-Szostak, E., Phosphorylation as a Method of Tuning the Enantiodiscrimination Potency of Quinine – an NMR Study. Chirality 2012, 24, 318. View at Publisher
  48. Berlicki, Ł.; Pilsl, L.; Wéber, E.; Mándity, I. M.; Cabrele, C.; Martinek, T. A.; Fülöp, F.; Reiser, O., Unique α,β- and α,α,β,β-peptide foldamers based on cis-β-aminocyclopentanecarboxylic acid. Angew. Chem. Int. Ed. Engl. 2012, 51, 2208. View at Publisher
  49. Kosikowska, P.; Berlicki, Ł., Urease inhibitors as potential drugs for gastric and urinary tract infections: A patent review. Expert Opin. Ther. Pat. 2011, 21, 945. View at Publisher
  50. Mucha, A.; Kafarski, P.; Berlicki, Ł., Remarkable potential of the alpha-aminophosphonate/phosphinate structural motif in medicinal chemistry. J. Med. Chem. 2011, 54, 5955. View at Publisher
  51. Rudzińska, E.; Dziędzioła, G.; Berlicki, Ł.; Kafarski, P., Enantiodifferentiation of alpha–Hydroxyalkanephosphonic Acids in 31P NMR with Application of alpha–Cyclodextrin as Chiral Discriminating Agent. Chirality 2010, 22, 63. View at Publisher
  52. Occhipinti, A.; Berlicki, Ł.; Giberti, S.; Dziędzioła, G.; Kafarski, P.; Forlani, G., Effectiveness and mode of action of phosphonate inhibitors of plant glutamine synthetase. Pest Manag. Sci. 2010, 66, 51. View at Publisher
  53. Vassiliou, S.; Kosikowska, P.; Grabowiecka, A.; Yiotakis, A.; Kafarski, P.; Berlicki, Ł., Computer-aided optimization of phosphinic inhibitors of bacterial ureases. J. Med. Chem. 2010, 53, 5597. View at Publisher
  54. Dąbrowska, E.; Burzyńska, A.; Mucha, A.; Matczak-Jon, E.; Sawka-Dobrowolska, W.; Berlicki, Ł.; Kafarski, P., Insight into the mechanism of three component condensation leading to aminomethylenebisphosphonates. J. Organomet. Chem. 2009, 694, 3806. View at Publisher
  55. Rudzińska, E.; Berlicki, Ł.; Kafarski, P.; Lammerhofer, M.; Mucha, A., Cinchona alkaloids as privileged chiral solvating agents for enantiodiscrimination of N-protected aminoalkanephosphonates - a comparative NMR study. Tetrahedron Asymmetry 2009, 20, 2709. View at Publisher
  56. Berlicki, Ł., Inhibitors of glutamine synthetase and their potential application in medicine. Mini-reviews Med. Chem. 2008, 8, 869.
  57. Forlani, G.; Occhipinti, A.; Berlicki, Ł.; Dziędzioła, G.; Wieczorek, A.; Kafarski, P. , Tailoring the Structure of Aminobisphosphonates to Target Plant P5C Reductase. J. Agric. Food Chem. 2008, 56, 3193. View at Publisher
  58. Vassiliou, S.; Grabowiecka, A.; Kosikowska, P.; Yiotakis, A.; Kafarski, P.; Berlicki, Ł., Design, synthesis and evaluation of novel organophosphorus inhibitors of bacterial ureases. J. Med. Chem. 2008, 51, 5736. View at Publisher
  59. Rudzińska, E.; Poliwoda, A.; Berlicki, Ł.; Mucha, A.; Dżygiel, P.; Wieczorek, P.P.; Kafarski, P., Enantiodifferentiation of N-benzyloxycarbonylaminophosphonic and phosphinic acids and their esters using cyclodextrins by means of capillary electrophoresis. J. Chromat. A 2007, 1138, 284. View at Publisher
  60. Berlicki, Ł.; Grembecka, J.; Dyguda-Kazimierowicz, E.; Kafarski, P.; Sokalski, W.A., From inhibitors of LAP to inhibitors of PAL. Lessons from Molecular Modeling and Experiment Interface. in Molecular Materials with Specific Interactions (Ed. W. A. Sokalski) 2007, 365.
  61. Forlani, G.; Giberti, S.; Berlicki, Ł.; Petrollino, D.; Kafarski, P., Plant P5C reductase as a new target for aminomethylenebisphosphonates. J. Agric. Food Chem. 2007, 55, 4340. View at Publisher
  62. Rudzińska, E.; Berlicki, Ł.; Mucha, A.; Kafarski, P., Analysis of pD Dependent Complexation of N-Benzyloxycarbonylaminophosphonic Acids by a-Cyclodextrin. Enantiodifferentation of Phosphonic Acid pKa V alues Chirality 2007, 19, 764. View at Publisher
  63. Młynarz, P.; Rudzińska, E.; Berlicki, Ł.; Kafarski, P., Organophosphorus supramolecular chemistry. Part 2. Organophosphorus receptors Curr. Org. Chem. 2007, 11, 1593.
  64. Rudzińska, E.; Berlicki, Ł.; Mucha, A.; Kafarski, P., Chiral discrimination of ethyl and phenyl N-benzyloxycarbonylaminophosphonates by cyclodextrins. Tetrahedron Asymmetry 2007, 18, 1579. View at Publisher
  65. Berlicki, Ł.; Mucha, A.; Kafarski, P., A mild and convenient oxidation of H-phosphinic acids. Pol. J. Chem. 2007, 81, 1959.
  66. Berlicki, Ł.; Kafarski, P., Computer-aided analysis of the interactions of glutamine synthetase with its inhibitors. Bioorg. Med. Chem. 2006, 14, 4578. View at Publisher
  67. Forlani, G.; Obojska, A.; Berlicki, Ł.; Kafarski, P., Phosphinothricin Analogues as Inhibitors of Plant Glutamine Synthetases. J. Agric. Food Chem. 2006, 54, 796. View at Publisher
  68. Berlicki, Ł.; Rudzińska, E.; Młynarz, P.; Kafarski, P., Organophosphorus supramolecular chemistry. Part 1. Receptors for organophosphorus compounds. Curr. Org. Chem. 2006, 10, 2285.
  69. Berlicki, Ł.; Obojska, A.; Forlani, G.; Kafarski, P., Design, Synthesis, and Activity of Analogues of Phosphinothricin as Inhibitors of Glutamine Synthetase. J. Med. Chem. 2005, 48, 6340. View at Publisher
  70. Berlicki, Ł.; Kafarski, P., Computer-Aided Analysis and Design of Phosphonic and Phosphinic Enzyme Inhibitors as Potential Drugs and Agrochemicals. Curr. Org. Chem. 2005, 9, 1829.
  71. Lejczak, B.; Wojtasek, H.; Berlicki, Ł.; Forlani, G.; Obojska, A.; Drąg. M.; Gąsowska, B.; Grembecka, J.; Olechnowicz. D., Design, Synthesis and Evaluation of Environmentally Friendly Herbicides. Pol. J. Environ. Stud. 2005, 14, 64.
  72. Berlicki, Ł.; Rudzińska, E.; Mucha, A.; Kafarski, P., Cyclodextrins as NMR probes in the study of the enantiomeric compositions of N-benzyloxycarbonylamino-phosphonic and phosphinic acids. Tetrahedron-Asymmetry 2004, 15, 1597. View at Publisher
  73. Obojska, A.; Berlicki, Ł.; Kafarski, P.; Lejczak, B.; Chicca, M.; Forlani, G., Herbicidal Pyridyl Derivatives of Aminomethylene-bisphosphonic Acid Inhibit Plant Glutamine Synthetase. J. Agric. Food. Chem. 2004, 52, 3337. View at Publisher
  74. Kafarski, P.; Berlicki, Ł., Rational design of herbicides. Pestycydy-Pesticides 2004, 2004, 7.
  75. Berlicki, Ł.; Rudzińska, E.; Kafarski, P., Enantiodifferentiation of aminophosphonic and aminophosphinic acids with alpha- and beta-cyclodextrins. Tetrahedron-Asymmetry 2003, 14, 1535. View at Publisher
  76. Kafarski, P.; Grembecka, J.; Mucha, A.; Pawełczak, M.; Drąg, M.; Berlicki, Ł.; Olechnowicz, D., Projektowanie Potencjalnych Leków i Pestycydów z Wykorzystaniem Wiedzy o Strukturze Przestrzennej Enzymów. Przem. Chem. 2003, 82, 1087.
  77. Berlicki, Ł., Projektowanie związków biologicznie czynnych przy użyciu struktury krystalicznej enzymu. Na pograniczu chemii i biologii 2003, 9, 59.
  78. Kafarski, P.; Drąg, M.; Berlicki, Ł.;Pawełczak, M., Synthesis and evaluation of phosphonopeptide Cathepsin C inhibitors. in Peptide Revolution: Genomics, Proteomics and Therapeutics, Eds. M. Chorev, T.K. Sawyer, Americam Peptide Society, Boston 2003, 310.
  79. Berlicki, Ł.; Kafarski, P., The use of molecular modelling for comparison of three possible modes of action of herbicidally active derivatives of aminomethylenebisphosphonic acid. Pest. Biochem. Physiol. 2002, 73, 94.